Expanded Access

Akamis Bio is a clinical-stage oncology company whose mission is to positively impact the lives of people living with cancer.

We currently have an early stage investigational medicine in our product pipeline for the treatment of locally advanced rectal cancer. Our goal is to provide access to our medicine at the appropriate time and in a manner that is most beneficial to the relevant patient population. We believe enrollment in our ongoing clinical trial is the safest and most effective way of
achieving this goal.

We do recognize that some patients will not be eligible for our clinical trial and may wish to access our product through expanded access. However, at this time, we do not have the resources available to offer expanded access use of our investigational medicine.

We encourage all patients and physicians who are interested in accessing our investigational medicine and finding out about enrolling in our clinical trial to visit our clinical trials page.

Akamis Bio may revise this expanded access policy at any time. Additionally, the posting of this policy by Akamis Bio does not serve as a guarantee of access to any specific investigational new drug by any individual patient.

If you have any questions, please reach out to us at [email protected].